Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization pharmacovigilance study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anticancer drug-induced life-threatening ventricular arrhythmias: a World Health Organization pharmacovigilance study
Authors
Keywords
-
Journal
EUROPEAN HEART JOURNAL
Volume -, Issue -, Pages -
Publisher
Oxford University Press (OUP)
Online
2021-05-27
DOI
10.1093/eurheartj/ehab362
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Uses of pharmacovigilance databases: an overview
- (2020) Kévin Bihan et al. THERAPIE
- Clinical Pharmacology and Interplay of Immune Checkpoint Agents: A Yin-Yang Balance
- (2020) Arthur Geraud et al. Annual Review of Pharmacology and Toxicology
- Ibrutinib-Mediated Atrial Fibrillation Due to Inhibition of CSK
- (2020) Ling Xiao et al. CIRCULATION
- A current understanding of drug-induced QT prolongation and its implications for anticancer therapy
- (2019) Dan M Roden CARDIOVASCULAR RESEARCH
- Androgenic Effects on Ventricular Repolarization
- (2019) Joe-Elie Salem et al. CIRCULATION
- Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study
- (2019) Melina Arnold et al. LANCET ONCOLOGY
- Cardiovascular Toxicities Associated With Ibrutinib
- (2019) Joe-Elie Salem et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Tyrosine Kinase Inhibitors in Leukemia and Cardiovascular Events
- (2019) Ali Manouchehri et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Cardiovascular Events Among Adults Treated With Chimeric Antigen Receptor T-Cells (CAR-T)
- (2019) Raza M. Alvi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Anticancer drug-induced cardiac rhythm disorders: Current knowledge and basic underlying mechanisms
- (2018) Joachim Alexandre et al. PHARMACOLOGY & THERAPEUTICS
- Association of Oral Contraceptives With Drug-Induced QT Interval Prolongation in Healthy Nonmenopausal Women
- (2018) Joe-Elie Salem et al. JAMA Cardiology
- Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
- (2018) Joe-Elie Salem et al. LANCET ONCOLOGY
- Cardiotoxic effects of anthracycline-based therapy: what is the evidence and what are the potential harms?
- (2017) Bennett E Levis et al. LANCET ONCOLOGY
- Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review
- (2017) Andreu Porta‐Sánchez et al. Journal of the American Heart Association
- VigiBase, the WHO Global ICSR Database System: Basic Facts
- (2017) Marie Lindquist DRUG INFORMATION JOURNAL
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
- (2016) Jose Luis Zamorano et al. EUROPEAN HEART JOURNAL
- Cardiovascular Toxic Effects of Targeted Cancer Therapies
- (2016) Javid J. Moslehi NEW ENGLAND JOURNAL OF MEDICINE
- Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
- (2016) Gabriel N. Hortobagyi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Meta-analysis of the risks of hypertension and QTc prolongation in patients with advanced non-small cell lung cancer who were receiving vandetanib
- (2015) Ying Liu et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- QT interval prolongation and torsades de pointes in a patient undergoing treatment with vorinostat: A case report and review of the literature
- (2012) Donald R. Lynch Jr et al. Cardiology Journal
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More